Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma

Bone Marrow Transplantation

Volumn 32, Issue 5, 2003, Pages 485-488

  Kanold, J ^a   Halle, P ^a   Tchirkov, A ^a   Berger, M ^a   Giarratana, M C ^b   Kobari, L ^b   Boiret, N ^a   Paillard, C ^a   Demeocq F ^a   Douay, L ^b  

^a Section of Radiology   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Ex vivo expansion; Neuroblastoma; Peripheral blood CD34 + cells

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; MESSENGER RNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; TYROSINE 3 MONOOXYGENASE; VINCRISTINE;

ADULT; ADVANCED CANCER; ARTICLE; BONE MARROW CELL; BONE MARROW PURGING; CELL NUCLEUS; CELL STRAIN; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COLONY FORMING UNIT GM; COMPUTER PROGRAM; CONTAMINATION; CONTROLLED STUDY; CULTURE MEDIUM; DONOR; HUMAN; HUMAN CELL; INCUBATION TIME; NEUROBLAST; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RNA TRANSCRIPTION; SAMPLING; SCREENING TEST; STATISTICAL ANALYSIS; TUMOR CELL;

ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL DIVISION; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; NEOPLASM CIRCULATING CELLS; NEOPLASM, RESIDUAL; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RNA, MESSENGER; RNA, NEOPLASM; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 10744221466     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704189     Document Type: Article

References (15)

1. Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-1173.
2. Hartmann O, Valteau-Couanet D, Vassal G et al. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution. Bone Marrow Transplant 1999; 23: 789-795.
3. Tchirkov A, Kanold J, Giollant M et al. Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection. Med Pediatr Oncol 1998; 30: 228-232.
4. Miyajima Y, Horibe K, Fukuda M et al. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 1996; 77: 1214-1219.
5. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 341: 85-86.
6. Moss TJ, Cairo M, Santana VM et al. Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation. Blood 1994; 83: 3085-3089.
7. Stiff P, Chen B, Franklin W et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 2000; 95: 2169-2174.
8. McNiece I, Jones R, Bearman SI et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001-3007.
9. Reiffers J, Cailliot C, Dazey B et al. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34+ cells. Lancet 1999; 354: 1092-1093.
10. Kobari L, Giarratana MC, Poloni A et al. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6. Bone Marrow Transplant 1998; 21: 759-767.
11. Kobari L, Pflumio F, Giarratana MC et al. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Exp Hematol 2000; 28: 1470-1480.
12. Berger M, Kanold J, Rapatel C et al. Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children. Bone Marrow Transplant 1997; 20: 191-198.
13. Douay L, Giarratana MC, Mary JY, Gorin NC. Interleukin 2 interacts with myeloid growth factors in serum-free long-term bone marrow culture. Br J Haematol 1994; 86: 475-482.
14. Boiret N, Kanold J, Fouassier M et al. CFU-MK content of immunoselected CD34+ peripheral progenitor evaluated with an adapted serum-free methylcellulose assay, is predictive of platelet lineage reconstitution in children with solid tumors. J Hematother Stem Cell Res 2000; 9: 525-534.
15. Kanold J, Yakouben K, Tchirkov A et al. Long-term results of CD34(+) cell transplantation in children with neuroblastoma. Med Pediatr Oncol 2000; 35: 1-7.